Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Comparing weekly and monthly auto buys for Dividend Aristocrats ETF reveals tradeoffs in cost, convenience, and growth potential. Pick the cadence that fits your plan.
16,949 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
CoreWeave faced a sharp move after its latest earnings, with shares slipping in after-hours trading despite a top-lin...
A forward-looking look at Compugen's 2025 earnings. Learn how pipeline progress, partnerships, and cash runway could ...
Quantum computing is moving from theory to real-world profit paths. This guide highlights two stocks and a practical ...
This week brought a sharp pullback in precious metals equities. We break down what drove the move, how it affects New...
A legendary investor makes a bold AI move. He recently closed a position in a company famous for aggressive AI spend ...
Goldman Sachs raises price targets on three major tech names by roughly 10%, reflecting improved growth visibility as...
Boston Omaha looks cheap on the surface, but a stock’s price can mislead. This article breaks down why governance and...
Can a warehouse club survive a downturn with steady footing? This article breaks down Costco’s unique model, historic...
When you hear an insider just sold 10,000 shares, it triggers questions. This guide explains how to interpret such mo...
Intel stock popped today as optimism about AI demand and data-center upgrades fed investor enthusiasm. This article b...
BTIG raises its price target on FTAI Aviation after the company boosted 2026 EBITDA guidance, arguing that a recoveri...